Start for free
Start for free
SC

Stonepine Capital Management

North America, Oregon, United States, Bend

Description

Stonepine Capital Management is a life science focused investment management company.

Investor Profile

Stonepine Capital Management has made 10 investments, with 4 in the past 12 months and 10% as lead.

Stage Focus

  • Post Ipo Equity (100%)

Country Focus

  • United States (60%)
  • Canada (20%)
  • Ireland (10%)
  • Sweden (10%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Pharmaceutical
  • Life Science
  • Therapeutics
  • Emergency Medicine
  • Information Technology
  • Health Diagnostics
  • Biopharma
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Stonepine Capital Management frequently co-invest with?

Nantahala Capital Management
Nantahala Capital Management
North America, Connecticut, United States, New Canaan
Co-Investments: 7
ADAR1 Capital Management
Co-Investments: 2
RA Capital Management
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 1
Bering Capital
Bering Capital
North America, California, United States, San Francisco
Co-Investments: 1
The Column Group
The Column Group
North America, California, United States, San Francisco
Co-Investments: 1
Soleus Capital
Soleus Capital
North America, Connecticut, United States, Greenwich
Co-Investments: 2
VC
Velan Capital
North America, Georgia, United States, Alpharetta
Co-Investments: 3
AP
Co-Investments: 2
Aisling Capital
Aisling Capital
North America, New York, United States, New York
Co-Investments: 1
SC
StemPoint Capital
North America, New York, United States, New York
Co-Investments: 1

What are some of recent deals done by Stonepine Capital Management?

Edesa Biotech

Markham, Ontario, Canada

Edesa develops treatments for dermatological and anorectal diseases. Edesa merged with Stellar Biotechnologies in 2019.

BiotechnologyLife Science
Post Ipo EquityFeb 13, 2025
Amount Raised: $10,509,103
Grace Therapeutics

Laval, Quebec, Canada

Grace Therapeutics is an emerging biopharmaceutical company.

BiotechnologyHealth CareMedicalPharmaceuticalTherapeutics
Post Ipo EquityFeb 10, 2025
Amount Raised: $10,467,142
Inhibikase Therapeutics

Atlanta, Georgia, United States

Inhibikase Therapeutics is a developer of cellular Abelson tyrosine kinase inhibitors to treat infections and other diseases.

Health CareHealth DiagnosticsTherapeutics
Post Ipo EquityOct 9, 2024
Amount Raised: $110,000,000
Tenax Therapeutics

Chapel Hill, North Carolina, United States

Tenax Therapeutics focuses on identifying and developing treatments that address cardiovascular and pulmonary diseases.

BiotechnologyHealth CareTherapeutics
Post Ipo EquityAug 6, 2024
Amount Raised: $100,000,000
Surrozen

South San Francisco, California, United States

Surrozen is a biopharmaceutical that focuses on unlocking the body’s regenerative power to treat injury and disease.

BiotechnologyEmergency MedicineHealth Care
Post Ipo EquityApr 1, 2024
Amount Raised: $17,500,000
Aprea

Stockholm, Stockholms Lan, Sweden

Aprea is a biopharmaceutical company that develops novel cancer therapeutics.

BiotechnologyHealth CareMedicalPersonal HealthPharmaceutical
Post Ipo EquityMar 11, 2024
Amount Raised: $16,000,000
Kiora Pharmaceuticals

Salt Lake City, Utah, United States

Kiora Pharmaceuticals develops medicines to treat eye diseases using its non-invasive, iontophoretic drug-delivery system.

BiotechnologyMedicalPharmaceutical
Post Ipo EquityJan 31, 2024
Amount Raised: $15,000,000
CalciMedica

La Jolla, California, United States

CalciMedica is engaged in the discovery and development of small molecule drugs for the treatment of inflammatory and autoimmune disorders.

Health CareInformation TechnologyLife Science
Post Ipo EquityJan 22, 2024
Amount Raised: $55,000,000
Aytu BioScience

Englewood, Colorado, United States

Aytu BioScience is a specialty healthcare company focused on developing treatments for urological and related conditions.

BiotechnologyHealth CareMedical
Post Ipo EquityJun 9, 2023
Amount Raised: $4,000,000
Amryt Pharma

Dublin, Dublin, Ireland

Amryt Pharma creates and delivers innovative treatments to help patients with rare and orphan diseases live better lives.

BiopharmaLife ScienceMedicalPharmaceutical
Post Ipo EquityDec 8, 2020
Amount Raised: $40,000,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator